Kestra Medical Technologies, Ltd. (KMTS) Misses Q4 EPS by 7c

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q4 EPS of ($0.64), $0.07 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $22.6 million, versus $21 million estimate.

For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.

You May Also Be Interested In

• Okta, Inc (OKTA) PT Raised to $235 at DA Davidson Following Oktane 2026
• Darden Restaurants falls as Q1 revenue misses expectations
• BlackBerry shares gain premarket as Q2 results, guidance beat estimates